← All organizations

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Academic/Hospital

Also known as: D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 1, 2017

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 2 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

allogeneic hematopoietic stem cells

Indications

Studied for

Recent trials (6)

NCT03177538Overall official - principal investigatorPhase 4Jun 1, 2017
NCT03166189Overall official - principal investigatorPhase 2Jun 1, 2017
NCT03166189Reponsible party - principal investigatorPhase 2Jun 1, 2017
NCT03177538Reponsible party - principal investigatorPhase 4Jun 1, 2017
NCT03166189Lead sponsorPhase 2Jun 1, 2017
NCT03177538Lead sponsorPhase 4Jun 1, 2017

Details

Last known activity: Jun 1, 2017